| bengalchemicals.com
↗ |
200 |
India drug patents, expiration dates and freedom-to-operate |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| bioblender.net
↗ |
200 |
Biotechblog – Biotechnology business, policy, and more! |
en |
biotech-and-biomedical-industryWordPress |
robotsllmsaihumans |
emailphone |
none |
| biocentre.org
↗ |
200 |
Biotechblog – Biotechnology business, policy, and more! |
en |
biotech-and-biomedical-industryWordPress |
robotsllmsaihumans |
emailphone |
none |
| biotechblog.com
↗ |
200 |
Biotechblog – Biotechnology business, policy, and more! |
en |
biotech-and-biomedical-industryWordPress |
robotsllmsaihumans |
emailphone |
none |
| chemicalpages.com
↗ |
200 |
United States: These 72 Drugs Face Patent Expirations and Generic Entry From 2026 - 2027 |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| drugpricetracker.com
↗ |
200 |
Current drugs and trends, generic vs. brand prices, and drug price spreads |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| fdaorangebook.com
↗ |
200 |
FDA Orange Book PDF library with historical archives from 1980-2026 |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| generabiotech.com
↗ |
200 |
thinkBiotech Global biopharmaceutical innovation expert witness and speaker - Yali Friedman, Ph.D. |
en |
biotech-and-biomedical-industry |
robotsllmsaihumans |
emailphone |
none |
| haitechemical.com
↗ |
200 |
United States: These 72 Drugs Face Patent Expirations and Generic Entry From 2026 - 2027 |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| iguanabio.com
↗ |
200 |
Biotechblog – Biotechnology business, policy, and more! |
en |
biotech-and-biomedical-industryWordPress |
robotsllmsaihumans |
emailphone |
none |
| intellivax.com
↗ |
200 |
GLAXOSMITHKLINE drug patent status, international patents |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| isopharmacy.com
↗ |
200 |
United States: These 72 Drugs Face Patent Expirations and Generic Entry From 2026 - 2027 |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| keryxbiopharm.com
↗ |
200 |
KERYX BIOPHARMS drug pipeline, global patents |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| koreanbio.org
↗ |
200 |
South Korea drug patents, expiration dates and freedom-to-operate |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| mwgbiotech.com
↗ |
200 |
Biotechblog – Biotechnology business, policy, and more! |
en |
biotech-and-biomedical-industryWordPress |
robotsllmsaihumans |
emailphone |
none |
| rxgap.com
↗ |
200 |
United States: These 72 Drugs Face Patent Expirations and Generic Entry From 2026 - 2027 |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |
| torreypinestherapeutics.com
↗ |
200 |
United States: These 71 Drugs Face Patent Expirations and Generic Entry From 2026 - 2027 |
en |
pharmaceutical-industry |
robotsllmsaihumans |
emailphone |
none |